IP Library Granted Patent US 10,900,040
Granted Patent B2
US 10,900,040 · App. 15/577,273 · Granted Jan 26, 2021

Methods of reducing or preventing intimal damage caused by mechanical stimulation of endothelial cells

Inventors: J. Marc Simard (Baltimore, MD); Sven Jacobson (New York, NY)
Assignees: University of Maryland, Baltimore; The United States of America as Represented by the Department of Veterans Affairs; Biogen Chesapeake, LLC
C12N15/1138A61K31/05A61K31/132A61K31/196A61K31/64A61P9/00A61P9/10A61M25/104C07K14/705C12N2310/11C12N2310/315
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,900,040
App. No.
15/577,273
Granted
Jan 26, 2021
Kind
B2
Abstract

Embodiments of the disclosure encompass methods and/or compositions for ameliorating or preventing intimal damage caused by mechanical stimulation of endothelial cells. The damage may be caused by use of a device within an artery, vein, or capillary of an individual, such as to remove a thrombus, an embolus or an atherosclerotic plaque in the vessel. Treatment and prevention embodiments concern therapeutically effective amounts of one or more antagonists of the SUR1-TRPM4 channel that is upregulated upon the mechanical stimulation.

Claims (9)

1. A method of inhibiting or reducing intimal damage caused by advance of a catheter through vasculature of a subject in need thereof comprising administering a therapeutically effective amount of glibenclamide or a pharmaceutically acceptable salt thereof to the subject, wherein the administering is solely local administration to increase local concentrations of the glibenclamide or pharmaceutically acceptable salt thereof in a blood vessel undergoing advance of the catheter.

2. The method of claim 1 , wherein the advance of a catheter through vasculature of the subject is during catheter angiography.

3. The method of claim 1 , wherein the advance of a catheter through vasculature of the subject causes endothelial dysfunction in a blood vessel of the subject.

4. The method of claim 1 , wherein the advance of a catheter through vasculature of the subject causes edema in a blood vessel of the subject.

5. The method of claim 1 , wherein the advance of a catheter through vasculature of the subject causes hemorrhage in a blood vessel of the subject.

6. The method of claim 1 , wherein the advance of a catheter through vasculature of the subject causes intimal dissection in arteries of the subject.

7. The method of claim 1 , wherein the advance of a catheter through vasculature of the subject is during a thrombectomy procedure.

8. The method of claim 1 , wherein the subject is undergoing or has undergone a procedure to remove or disrupt a thrombus or embolus or atherosclerotic plaque in a blood vessel.

9. The method of claim 1 , wherein the subject is undergoing or has undergone a endovascular aneurysm repair procedure.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2023
From: BIOGEN CHESAPEAKE LLC
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 064678/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: SIMARD, J. MARC
To: UNIVERSITY OF MARYLAND, BALTIMORE
Reel/Frame 044374/0961 →
ASSIGNMENT OF A JOINT UNDIVIDED RIGHT, TITLE AND INTEREST Recorded Dec 12, 2017
From: UNIVERSITY OF MARYLAND, BALTIMORE
To: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 044849/0153 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2017
From: JACOBSON, SVEN
To: REMEDY PHARMACEUTICALS, INC.
Reel/Frame 044849/0185 →
ASSIGNMENT OF A JOINT UNDIVIDED RIGHT, TITLE AND INTEREST Recorded Dec 12, 2017
From: REMEDY PHARMACEUTICALS, INC.
To: BIOGEN CHESAPEAKE, LLC
Reel/Frame 044849/0256 →
Continuity (2)
Provisional Application 62168589 · May 29, 2015
Related Publication 20180155727A1 · Jun 7, 2018